These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18801352)

  • 1. High-sensitivity C-reactive protein: discriminator between patients with primary and secondary antiphospholipid syndrome.
    Bećarević M; Majkić-Singh N
    Clin Biochem; 2008 Dec; 41(18):1449-53. PubMed ID: 18801352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
    Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O
    J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
    Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
    Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome].
    Aleksandrova EN; Novikov AA; Popkova TV; Reshetniak TM; Novikova DS; Kliukvina NG; Il'ina AE; Mach ES; Volkov AV; Nasonov EL
    Ter Arkh; 2006; 78(6):35-9. PubMed ID: 16881361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and immunological characteristics of primary and secondary antiphospholipid syndrome].
    Sulut'ian AE; Chapaeva NN; Shirinskiĭ VS; Kozhevnikov VS; Kozlov VA
    Klin Med (Mosk); 2004; 82(8):39-43. PubMed ID: 15468724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A in autoimmune thrombosis.
    Sodin-Semrl S; Zigon P; Cucnik S; Kveder T; Blinc A; Tomsic M; Rozman B
    Autoimmun Rev; 2006 Nov; 6(1):21-7. PubMed ID: 17110312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C-reactive protein in SLE males: contribution to thrombotic complications].
    Kliukvina NG; Baranov AA; Aleksandrova EN; Nasonov EL
    Klin Med (Mosk); 1997; 75(8):24-7. PubMed ID: 9340432
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
    Bećarevic M; Andrejević S; Bonaci-Nikolić B; Obradović I; Miljić P; Majkić-Singh N
    Clin Lab; 2005; 51(5-6):279-83. PubMed ID: 15991801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum nitrates in patients with systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak DV; Kuznetsova TV; Kobylianskiĭ AG; Kliukvina NG; Reshetniak TM; Nasonov EL
    Ter Arkh; 2004; 76(5):19-22. PubMed ID: 15230126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in patients with primary antiphospholipid syndrome.
    Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
    Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with primary antiphospholipid syndrome and coronary microvascular dysfunction--a distinct clinical subset.
    Tănăseanu C; Moldoveanu E; Tănăseanu S; Popescu M; Dumitraşcu A; Tamşulea I; Urban A; Grecu V; Neagu M; Manea G; Marta D
    Rom J Intern Med; 2004; 42(3):545-56. PubMed ID: 16370053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity?
    Andreoli L; Pregnolato F; Burlingame RW; Allegri F; Rizzini S; Fanelli V; Radice A; Corace C; Sinico RA; Meroni PL; Tincani A
    J Autoimmun; 2008; 30(1-2):51-7. PubMed ID: 18191541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
    Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
    Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.